ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,335.095
-0.09%
Brent Oil
82.04
0.07%
Bitcoin
68,764.88
0.37%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Reata Pharmaceuticals Inc (RETA)

  7. Reata Pharmaceuticals Inc (RETA) News

Reata Pharmaceuticals (RETA)

Reata Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RETA
DateTimeSourceHeadlineSymbolCompany
06/10/202321:07Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RETAReata Pharmaceuticals Inc
28/09/202321:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RETAReata Pharmaceuticals Inc
27/09/202300:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202322:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:25Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:23Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:17Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202321:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
26/09/202313:59GlobeNewswire Inc.Biogen Completes Acquisition of Reata PharmaceuticalsNASDAQ:RETAReata Pharmaceuticals Inc
21/09/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RETAReata Pharmaceuticals Inc
21/09/202315:08Business WireReata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.NASDAQ:RETAReata Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RETA

Your Recent History

LSE
FLTR
Flutter Entertainment
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved